Navigation Links
The Quantum Group Announces Standing-Room-Only PWeR(TM) Demonstrations at Pri-Med South Expo
Date:2/17/2009

WELLINGTON, Fla., Feb. 17 /PRNewswire-FirstCall/ -- The Quantum Group, Inc. (NYSE Amex: QGP) (www.QuantumMD.com) announced today that PWeR(TM) (Personal Wellness electronic Record) demonstrations presented at the 2009 Pri-Med South Conference and Expo were met with standing room only crowds throughout the 3-day event.

Pete Martinez, Quantum Senior Vice President and Chief Technology & Innovations Officer, led the team responsible for the development of PWeR. Martinez delivered each of the presentations which lasted approximately 45 minutes each. Attendees arrived with ample time preceding each of the scheduled presentations to ensure they would have a seat.

Martinez offered his comments on the event. "This was an exciting weekend for our Company. We were able to utilize the brand recognition of the foundation of our Company, Renaissance Health Systems, to introduce PWeR to the thousands of physician, nurse and staff attendees. We entered the weekend confident in our service-oriented and patient-centric architected platform and concluded it with positive feedback that exceeded our expectations."

Noel J. Guillama, Quantum President & CEO commented, "We are more than an EMR application, and that was crystal clear this weekend. EMR is simply one application of PWeR and so many of the providers we spoke with were eager to schedule a personalized demonstration of the system to see how their practice can be quickly, easily and affordably equipped with 21st Century technology."

PWeR is a service-oriented technology platform that connects all of the applications and systems used by physician/provider, hospital, clinic and related professionals in one web-based, patient-centric database.

About The Quantum Group, Inc.

The Quantum Group is an innovation-driven Healthcare Services Organization (HSO) which provides business process solutions, service chain management, strategic consulting and leading edge technology innovations to the healthcare industry.

Through our dynamic patient-centric architecture, we empower the communication that is critical for the coordination of care and take aim at the $700 billion inefficiency gap in the United States healthcare industry. We are guided by a mission to develop efficiencies, improve the quality of patient care and achieve cost reductions for the nation's largest and fastest growing industry.

We have developed leading-edge technology with the creation and deployment of a series of innovative patent-pending initiatives. Through approximately 2,000 healthcare providers and multiple insurance company relationships under management, we are positioned to be a catalyst for change to the healthcare industry.

Certain statements contained in this news release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective company's Securities and Exchange Commission 10-KSB, 10-QSB, S-8, SB-2, S-1 and 8-K filings (and amendments thereto) that may cause actual results to materially differ from projections. Forward-looking statements can be identified by the use of words such as "expects," "plans," "will," "may," "anticipates," "believes," "should," "intends," "estimates" "could" and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by these forward-looking statements. Such risk factors include, without limitation, the ability of the Company to properly execute its business model, to raise substantial and immediate additional capital to implement its business model, to continue revenue growth trend in fiscal year 2009, to control patient medical cost relative to income received, to attract and retain executive, management and operational personnel, to continue growing its patient base, to negotiate favorable current debt and future capital raises, to negotiate favorable agreements with a diversified provider base and to continue to supply the services needed by its HMO clients as well as physician clients. We have further risk in the deployment of our technology platform, the utilization by our clients, technical and software setbacks, cost of development, as well as the capital to deploy it. We are subject further to interruptions of service. Company does not undertake any obligation to publicly update any forward-looking statements. As a result, investors should not place undue reliance on these forward-looking statements.

                       FOR MORE INFORMATION, PLEASE CONTACT:
                             PR Financial Marketing
                           Jim Blackman: 713-256-0369
                              jim@prfmonline.com
                                     or
                             The Quantum Group, Inc.
                         Danielle Amodio:  561.798.9800
                             DAmodio@QuantumMD.com


'/>"/>
SOURCE The Quantum Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The Quantum Group Reports Year End Results for Fiscal Year 2008
2. Quantum Executive Pete Martinez Invited to Participate in University Health Seminar
3. The Quantum Group Announces Support of Technology Bill Before Congress
4. The Quantum Group and IBM Announce Hosting Agreement for Advanced Healthcare Solutions
5. The Quantum Group CEO Offers Year in Review
6. MyHealthArchive.coms New Features -- A Quantum Leap in Using Health Information to Promote Your Health
7. The Quantum Group Announces State Approval of TPA Application for Subsidiary Company Renaissance Administrative Solutions, Inc.
8. The Quantum Group Announces Continued Growth of Patient Base and Preliminary Revenue Guidance
9. The Quantum Group Inc. Announces Expansion into Three Florida Counties
10. The Quantum Group Inc. To Present at Paulson Investments 31st Annual Westergaard Conference
11. The Quantum Group to Present at the Noble Financial Equity Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... announces today that the University of Pittsburgh Medical Center (UPMC) will acquire QuikClot® ... Western Pennsylvania. , The program, developed in association with efforts by the American ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... leading physicians, Paul Yost, will begin serving as new board chair for Orange ... month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s term, ...
(Date:3/28/2017)... ... 2017 , ... In its ongoing effort to educate consumers ... and published an informational resource that addresses frequently asked questions. , “ ... site’s team of third party administrator (TPA) contributors regularly receives as employers, benefit ...
(Date:3/28/2017)... Santa Monica, CA (PRWEB) , ... March 28, ... ... expert, Dr. Carson Liu of SkyLex Advanced Surgical, Inc. is thrilled to offer ... newest gastric balloon procedure, and this procedure adds to SkyLex Advanced Surgical’s ...
(Date:3/28/2017)... ... ... a common and unwelcomed occurrence in people of all ages, genders and ethnicities. Dermatologist Dr. ... of dealing with excess skin oil. “Oily skin is a challenge to many of my ... the oily shine while keeping the skin fresh and clean,” says Dr. Au. , What ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 27, 2017   Pulmatrix, Inc . (NASDAQ: PULM), a ... serious pulmonary diseases, today announced that it has added two ... and asthma to its Scientific Advisory Board . ... Richard B. Moss , MD, former chief of the Pediatric ... Fibrosis Center at Stanford University, and ...
(Date:3/27/2017)... , March 27, 2017 ... to reach USD 16.0 billion by 2025, according to ... growing prevalence of chronic diseases is anticipated to be ... analyzers, which thereby widens the scope for growth during ... and bariatric population, which is highly susceptible to chronic ...
(Date:3/27/2017)... BOSTON , March 27, 2017  Allergan ... and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical ... innovative therapies based upon tetracycline chemistry, announced that ... the treatment of moderate to severe acne met ... a once-daily, oral, narrow spectrum tetracycline-derived antibiotic with ...
Breaking Medicine Technology: